inclusion criteria: 1. adult males and females aged 19 years or older (or minimum age for adulthood or for informed consent below 19 years for each country) 2. patients with body weight ≥45 kg at screening 3. patients with covid-19 confirmed by rt-pcr before randomization 4. patients confirmed with mild or moderate covid-19, along with one or more symptoms in association with covid-19 within 5 days before randomization, who do not need adjunctive oxygen therapy 5. patients who are fully informed of this study, voluntarily decide to participate in this study and provide written consent to comply with requirements for this study

inclusion criteria: 1. adult males and females aged 19 years or older (or minimum age for adulthood or for informed consent below 19 years for each country) 2. patients with body weight ≥45 kg at screening 3. patients with covid-19 confirmed by rt-pcr before randomization 4. patients confirmed with mild or moderate covid-19, along with one or more symptoms in association with covid-19 within 5 days before randomization, who do not need adjunctive oxygen therapy 5. patients who are fully informed of this study, voluntarily decide to participate in this study and provide written consent to comply with requirements for this study

inclusion criteria: adult males and females aged 19 years or older (or minimum age for adulthood or for informed consent below 19 years for each country) patients with body weight ≥45 kg at screening patients with covid-19 confirmed by rt-pcr before randomization patients confirmed with mild or moderate covid-19, along with one or more symptoms in association with covid-19 within 5 days before randomization, who do not need adjunctive oxygen therapy patients who are fully informed of this study, voluntarily decide to participate in this study and provide written consent to comply with requirements for this study

inclusion criteria: adult males and females aged 19 years or older (or minimum age for adulthood or for informed consent below 19 years for each country) patients with body weight ≥45 kg at screening patients with covid-19 confirmed by rt-pcr before randomization patients confirmed with mild or moderate covid-19, along with one or more symptoms in association with covid-19 within 5 days before randomization, who do not need adjunctive oxygen therapy patients who are fully informed of this study, voluntarily decide to participate in this study and provide written consent to comply with requirements for this study

inclusion criteria: 1. adult males and females aged 19 years or older (or minimum age for adulthood or for informed consent below 19 years for each country) 2. patients with body weight ≥45 kg at screening 3. patients with covid-19 confirmed by rt-pcr before randomization 4. patients confirmed with mild or moderate covid-19, along with one or more symptoms in association with covid-19 within 5 days before randomization, who do not need adjunctive oxygen therapy 5. patients who are fully informed of this study, voluntarily decide to participate in this study and provide written consent to comply with requirements for this study

inclusion criteria: 1. adult males and females aged 19 years or older (or minimum age for adulthood or for informed consent below 19 years for each country) 2. patients with body weight ≥45 kg at screening 3. patients with covid-19 confirmed by rt-pcr before randomization 4. patients confirmed with mild or moderate covid-19, along with one or more symptoms in association with covid-19 within 5 days before randomization, who do not need adjunctive oxygen therapy 5. patients who are fully informed of this study, voluntarily decide to participate in this study and provide written consent to comply with requirements for this study